Nanotech Investing Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT XR in the Journal of Clinical Endocrinology and Metabolism
Nanotech Investing Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
Nanotech Investing Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
Nanotech Investing Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
Nanotech Investing Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Nanotech Investing Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Nanotech Investing Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Nanotech Investing Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy
Nanotech Investing Vaxcyte Doses First Participants in the OPUS Phase 3, Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
Nanotech Investing Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
SAGA Metals Highlights Radar Titanium Opportunity as North America Confronts Defense Driven Titanium Supply Chain Risks
RETRANSMISSION: Blackrock Silver Closes C$15 Million Private Placement Led By a C$7 Million Investment from Eric Sprott
